BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 12746701)

  • 1. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials of botulinum toxin in the treatment of spasticity.
    Simpson DM
    Muscle Nerve Suppl; 1997; 6():S169-75. PubMed ID: 9826988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M; Compère S; Launay MJ; Kozlowski O
    J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin: from spasticity reliever to a neuromotor re-learning tool.
    Krishnan RV
    Int J Neurosci; 2005 Oct; 115(10):1451-67. PubMed ID: 16162450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size.
    Cousins E; Ward A; Roffe C; Rimington L; Pandyan A
    Clin Rehabil; 2010 Jun; 24(6):501-13. PubMed ID: 20483887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
    Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
    Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
    O'Brien CF
    Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin in poststroke spasticity.
    Ozcakir S; Sivrioglu K
    Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections.
    Keren-Capelovitch T; Jarus T; Fattal-Valevski A
    J Child Neurol; 2010 Jun; 25(6):694-700. PubMed ID: 20508235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.